Global Postoperative Nausea and Vomiting (PONV) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Postoperative Nausea and Vomiting (PONV) market size was valued at US$ 1871.9 million in 2023. With growing demand in downstream market, the Postoperative Nausea and Vomiting (PONV) is forecast to a readjusted size of US$ 2955.6 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Postoperative Nausea and Vomiting (PONV) market. Postoperative Nausea and Vomiting (PONV) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Postoperative Nausea and Vomiting (PONV). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Postoperative Nausea and Vomiting (PONV) market.
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
Key Features:
The report on Postoperative Nausea and Vomiting (PONV) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Postoperative Nausea and Vomiting (PONV) market. It may include historical data, market segmentation by Type (e.g., Serotonin Antagonists, Steroids), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Postoperative Nausea and Vomiting (PONV) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Postoperative Nausea and Vomiting (PONV) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Postoperative Nausea and Vomiting (PONV) industry. This include advancements in Postoperative Nausea and Vomiting (PONV) technology, Postoperative Nausea and Vomiting (PONV) new entrants, Postoperative Nausea and Vomiting (PONV) new investment, and other innovations that are shaping the future of Postoperative Nausea and Vomiting (PONV).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Postoperative Nausea and Vomiting (PONV) market. It includes factors influencing customer ' purchasing decisions, preferences for Postoperative Nausea and Vomiting (PONV) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Postoperative Nausea and Vomiting (PONV) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Postoperative Nausea and Vomiting (PONV) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Postoperative Nausea and Vomiting (PONV) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Postoperative Nausea and Vomiting (PONV) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Postoperative Nausea and Vomiting (PONV) market.
Market Segmentation:
Postoperative Nausea and Vomiting (PONV) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Postoperative Nausea and Vomiting (PONV) market size was valued at US$ 1871.9 million in 2023. With growing demand in downstream market, the Postoperative Nausea and Vomiting (PONV) is forecast to a readjusted size of US$ 2955.6 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Postoperative Nausea and Vomiting (PONV) market. Postoperative Nausea and Vomiting (PONV) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Postoperative Nausea and Vomiting (PONV). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Postoperative Nausea and Vomiting (PONV) market.
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
Key Features:
The report on Postoperative Nausea and Vomiting (PONV) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Postoperative Nausea and Vomiting (PONV) market. It may include historical data, market segmentation by Type (e.g., Serotonin Antagonists, Steroids), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Postoperative Nausea and Vomiting (PONV) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Postoperative Nausea and Vomiting (PONV) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Postoperative Nausea and Vomiting (PONV) industry. This include advancements in Postoperative Nausea and Vomiting (PONV) technology, Postoperative Nausea and Vomiting (PONV) new entrants, Postoperative Nausea and Vomiting (PONV) new investment, and other innovations that are shaping the future of Postoperative Nausea and Vomiting (PONV).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Postoperative Nausea and Vomiting (PONV) market. It includes factors influencing customer ' purchasing decisions, preferences for Postoperative Nausea and Vomiting (PONV) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Postoperative Nausea and Vomiting (PONV) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Postoperative Nausea and Vomiting (PONV) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Postoperative Nausea and Vomiting (PONV) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Postoperative Nausea and Vomiting (PONV) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Postoperative Nausea and Vomiting (PONV) market.
Market Segmentation:
Postoperative Nausea and Vomiting (PONV) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Serotonin Antagonists
- Steroids
- Dopamine Antagonists
- NK-1 Receptor Antagonists
- Non-pharmacologic Treatment
- Others
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Acacia Pharma
- F. Hoffmann-La Roche
- Novartis
- Ani Pharmaceuticals
- Camurus
- Sanofi
- Helsinn Holding
- Eisai
- Merck
- GlaxoSmithKline
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Postoperative Nausea and Vomiting (PONV) Market Size 2019-2030
2.1.2 Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Postoperative Nausea and Vomiting (PONV) Segment by Type
2.2.1 Serotonin Antagonists
2.2.2 Steroids
2.2.3 Dopamine Antagonists
2.2.4 NK-1 Receptor Antagonists
2.2.5 Non-pharmacologic Treatment
2.2.6 Others
2.3 Postoperative Nausea and Vomiting (PONV) Market Size by Type
2.3.1 Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
2.4 Postoperative Nausea and Vomiting (PONV) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Postoperative Nausea and Vomiting (PONV) Market Size by Application
2.5.1 Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
3 POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SIZE BY PLAYER
3.1 Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Players
3.1.1 Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2019-2024)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2019-2024)
3.2 Global Postoperative Nausea and Vomiting (PONV) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POSTOPERATIVE NAUSEA AND VOMITING (PONV) BY REGIONS
4.1 Postoperative Nausea and Vomiting (PONV) Market Size by Regions (2019-2024)
4.2 Americas Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
4.3 APAC Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
4.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
4.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024)
5.2 Americas Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
5.3 Americas Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Postoperative Nausea and Vomiting (PONV) Market Size by Region (2019-2024)
6.2 APAC Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
6.3 APAC Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Postoperative Nausea and Vomiting (PONV) by Country (2019-2024)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) by Region (2019-2024)
8.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
8.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET FORECAST
10.1 Global Postoperative Nausea and Vomiting (PONV) Forecast by Regions (2025-2030)
10.1.1 Global Postoperative Nausea and Vomiting (PONV) Forecast by Regions (2025-2030)
10.1.2 Americas Postoperative Nausea and Vomiting (PONV) Forecast
10.1.3 APAC Postoperative Nausea and Vomiting (PONV) Forecast
10.1.4 Europe Postoperative Nausea and Vomiting (PONV) Forecast
10.1.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Forecast
10.2 Americas Postoperative Nausea and Vomiting (PONV) Forecast by Country (2025-2030)
10.2.1 United States Postoperative Nausea and Vomiting (PONV) Market Forecast
10.2.2 Canada Postoperative Nausea and Vomiting (PONV) Market Forecast
10.2.3 Mexico Postoperative Nausea and Vomiting (PONV) Market Forecast
10.2.4 Brazil Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3 APAC Postoperative Nausea and Vomiting (PONV) Forecast by Region (2025-2030)
10.3.1 China Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.2 Japan Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.3 Korea Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.4 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.5 India Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.6 Australia Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4 Europe Postoperative Nausea and Vomiting (PONV) Forecast by Country (2025-2030)
10.4.1 Germany Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.2 France Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.3 UK Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.4 Italy Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.5 Russia Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Forecast by Region (2025-2030)
10.5.1 Egypt Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.2 South Africa Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.3 Israel Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.4 Turkey Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.5 GCC Countries Postoperative Nausea and Vomiting (PONV) Market Forecast
10.6 Global Postoperative Nausea and Vomiting (PONV) Forecast by Type (2025-2030)
10.7 Global Postoperative Nausea and Vomiting (PONV) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Information
11.1.2 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Offered
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Acacia Pharma Main Business Overview
11.1.5 Acacia Pharma Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Offered
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Postoperative Nausea and Vomiting (PONV) Product Offered
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Information
11.4.2 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Offered
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Ani Pharmaceuticals Main Business Overview
11.4.5 Ani Pharmaceuticals Latest Developments
11.5 Camurus
11.5.1 Camurus Company Information
11.5.2 Camurus Postoperative Nausea and Vomiting (PONV) Product Offered
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Camurus Main Business Overview
11.5.5 Camurus Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Postoperative Nausea and Vomiting (PONV) Product Offered
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Information
11.7.2 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Offered
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Helsinn Holding Main Business Overview
11.7.5 Helsinn Holding Latest Developments
11.8 Eisai
11.8.1 Eisai Company Information
11.8.2 Eisai Postoperative Nausea and Vomiting (PONV) Product Offered
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eisai Main Business Overview
11.8.5 Eisai Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Postoperative Nausea and Vomiting (PONV) Product Offered
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Offered
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GlaxoSmithKline Main Business Overview
11.10.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Postoperative Nausea and Vomiting (PONV) Market Size 2019-2030
2.1.2 Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Postoperative Nausea and Vomiting (PONV) Segment by Type
2.2.1 Serotonin Antagonists
2.2.2 Steroids
2.2.3 Dopamine Antagonists
2.2.4 NK-1 Receptor Antagonists
2.2.5 Non-pharmacologic Treatment
2.2.6 Others
2.3 Postoperative Nausea and Vomiting (PONV) Market Size by Type
2.3.1 Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
2.4 Postoperative Nausea and Vomiting (PONV) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Postoperative Nausea and Vomiting (PONV) Market Size by Application
2.5.1 Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
3 POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET SIZE BY PLAYER
3.1 Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Players
3.1.1 Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2019-2024)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2019-2024)
3.2 Global Postoperative Nausea and Vomiting (PONV) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POSTOPERATIVE NAUSEA AND VOMITING (PONV) BY REGIONS
4.1 Postoperative Nausea and Vomiting (PONV) Market Size by Regions (2019-2024)
4.2 Americas Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
4.3 APAC Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
4.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
4.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024)
5.2 Americas Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
5.3 Americas Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Postoperative Nausea and Vomiting (PONV) Market Size by Region (2019-2024)
6.2 APAC Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
6.3 APAC Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Postoperative Nausea and Vomiting (PONV) by Country (2019-2024)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) by Region (2019-2024)
8.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024)
8.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) MARKET FORECAST
10.1 Global Postoperative Nausea and Vomiting (PONV) Forecast by Regions (2025-2030)
10.1.1 Global Postoperative Nausea and Vomiting (PONV) Forecast by Regions (2025-2030)
10.1.2 Americas Postoperative Nausea and Vomiting (PONV) Forecast
10.1.3 APAC Postoperative Nausea and Vomiting (PONV) Forecast
10.1.4 Europe Postoperative Nausea and Vomiting (PONV) Forecast
10.1.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Forecast
10.2 Americas Postoperative Nausea and Vomiting (PONV) Forecast by Country (2025-2030)
10.2.1 United States Postoperative Nausea and Vomiting (PONV) Market Forecast
10.2.2 Canada Postoperative Nausea and Vomiting (PONV) Market Forecast
10.2.3 Mexico Postoperative Nausea and Vomiting (PONV) Market Forecast
10.2.4 Brazil Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3 APAC Postoperative Nausea and Vomiting (PONV) Forecast by Region (2025-2030)
10.3.1 China Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.2 Japan Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.3 Korea Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.4 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.5 India Postoperative Nausea and Vomiting (PONV) Market Forecast
10.3.6 Australia Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4 Europe Postoperative Nausea and Vomiting (PONV) Forecast by Country (2025-2030)
10.4.1 Germany Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.2 France Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.3 UK Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.4 Italy Postoperative Nausea and Vomiting (PONV) Market Forecast
10.4.5 Russia Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Forecast by Region (2025-2030)
10.5.1 Egypt Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.2 South Africa Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.3 Israel Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.4 Turkey Postoperative Nausea and Vomiting (PONV) Market Forecast
10.5.5 GCC Countries Postoperative Nausea and Vomiting (PONV) Market Forecast
10.6 Global Postoperative Nausea and Vomiting (PONV) Forecast by Type (2025-2030)
10.7 Global Postoperative Nausea and Vomiting (PONV) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Information
11.1.2 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Offered
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Acacia Pharma Main Business Overview
11.1.5 Acacia Pharma Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Offered
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Postoperative Nausea and Vomiting (PONV) Product Offered
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Information
11.4.2 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Offered
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Ani Pharmaceuticals Main Business Overview
11.4.5 Ani Pharmaceuticals Latest Developments
11.5 Camurus
11.5.1 Camurus Company Information
11.5.2 Camurus Postoperative Nausea and Vomiting (PONV) Product Offered
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Camurus Main Business Overview
11.5.5 Camurus Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Postoperative Nausea and Vomiting (PONV) Product Offered
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Information
11.7.2 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Offered
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Helsinn Holding Main Business Overview
11.7.5 Helsinn Holding Latest Developments
11.8 Eisai
11.8.1 Eisai Company Information
11.8.2 Eisai Postoperative Nausea and Vomiting (PONV) Product Offered
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eisai Main Business Overview
11.8.5 Eisai Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Postoperative Nausea and Vomiting (PONV) Product Offered
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Offered
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GlaxoSmithKline Main Business Overview
11.10.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Serotonin Antagonists
Table 3. Major Players of Steroids
Table 4. Major Players of Dopamine Antagonists
Table 5. Major Players of NK-1 Receptor Antagonists
Table 6. Major Players of Non-pharmacologic Treatment
Table 7. Major Players of Others
Table 8. Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 11. Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 14. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Player (2019-2024)
Table 16. Postoperative Nausea and Vomiting (PONV) Key Players Head office and Products Offered
Table 17. Postoperative Nausea and Vomiting (PONV) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Regions (2019-2024)
Table 22. Global Postoperative Nausea and Vomiting (PONV) Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Country (2019-2024)
Table 26. Americas Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 28. Americas Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 30. APAC Postoperative Nausea and Vomiting (PONV) Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region (2019-2024)
Table 32. APAC Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 34. APAC Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 36. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Country (2019-2024)
Table 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 40. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Postoperative Nausea and Vomiting (PONV)
Table 49. Key Market Challenges & Risks of Postoperative Nausea and Vomiting (PONV)
Table 50. Key Industry Trends of Postoperative Nausea and Vomiting (PONV)
Table 51. Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Acacia Pharma Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 56. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Offered
Table 57. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Acacia Pharma Main Business
Table 59. Acacia Pharma Latest Developments
Table 60. F. Hoffmann-La Roche Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 61. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Offered
Table 62. F. Hoffmann-La Roche Main Business
Table 63. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. F. Hoffmann-La Roche Latest Developments
Table 65. Novartis Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 66. Novartis Postoperative Nausea and Vomiting (PONV) Product Offered
Table 67. Novartis Main Business
Table 68. Novartis Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Novartis Latest Developments
Table 70. Ani Pharmaceuticals Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 71. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Offered
Table 72. Ani Pharmaceuticals Main Business
Table 73. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Ani Pharmaceuticals Latest Developments
Table 75. Camurus Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 76. Camurus Postoperative Nausea and Vomiting (PONV) Product Offered
Table 77. Camurus Main Business
Table 78. Camurus Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Camurus Latest Developments
Table 80. Sanofi Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 81. Sanofi Postoperative Nausea and Vomiting (PONV) Product Offered
Table 82. Sanofi Main Business
Table 83. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Sanofi Latest Developments
Table 85. Helsinn Holding Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 86. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Offered
Table 87. Helsinn Holding Main Business
Table 88. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Helsinn Holding Latest Developments
Table 90. Eisai Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 91. Eisai Postoperative Nausea and Vomiting (PONV) Product Offered
Table 92. Eisai Main Business
Table 93. Eisai Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Eisai Latest Developments
Table 95. Merck Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 96. Merck Postoperative Nausea and Vomiting (PONV) Product Offered
Table 97. Merck Main Business
Table 98. Merck Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Merck Latest Developments
Table 100. GlaxoSmithKline Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 101. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Offered
Table 102. GlaxoSmithKline Main Business
Table 103. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. GlaxoSmithKline Latest Developments
Table 1. Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Serotonin Antagonists
Table 3. Major Players of Steroids
Table 4. Major Players of Dopamine Antagonists
Table 5. Major Players of NK-1 Receptor Antagonists
Table 6. Major Players of Non-pharmacologic Treatment
Table 7. Major Players of Others
Table 8. Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 11. Postoperative Nausea and Vomiting (PONV) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 14. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Player (2019-2024)
Table 16. Postoperative Nausea and Vomiting (PONV) Key Players Head office and Products Offered
Table 17. Postoperative Nausea and Vomiting (PONV) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Regions (2019-2024)
Table 22. Global Postoperative Nausea and Vomiting (PONV) Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Country (2019-2024)
Table 26. Americas Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 28. Americas Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 30. APAC Postoperative Nausea and Vomiting (PONV) Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region (2019-2024)
Table 32. APAC Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 34. APAC Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 36. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Country (2019-2024)
Table 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 40. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Postoperative Nausea and Vomiting (PONV)
Table 49. Key Market Challenges & Risks of Postoperative Nausea and Vomiting (PONV)
Table 50. Key Industry Trends of Postoperative Nausea and Vomiting (PONV)
Table 51. Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Acacia Pharma Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 56. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Offered
Table 57. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Acacia Pharma Main Business
Table 59. Acacia Pharma Latest Developments
Table 60. F. Hoffmann-La Roche Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 61. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Offered
Table 62. F. Hoffmann-La Roche Main Business
Table 63. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. F. Hoffmann-La Roche Latest Developments
Table 65. Novartis Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 66. Novartis Postoperative Nausea and Vomiting (PONV) Product Offered
Table 67. Novartis Main Business
Table 68. Novartis Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Novartis Latest Developments
Table 70. Ani Pharmaceuticals Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 71. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Offered
Table 72. Ani Pharmaceuticals Main Business
Table 73. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Ani Pharmaceuticals Latest Developments
Table 75. Camurus Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 76. Camurus Postoperative Nausea and Vomiting (PONV) Product Offered
Table 77. Camurus Main Business
Table 78. Camurus Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Camurus Latest Developments
Table 80. Sanofi Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 81. Sanofi Postoperative Nausea and Vomiting (PONV) Product Offered
Table 82. Sanofi Main Business
Table 83. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Sanofi Latest Developments
Table 85. Helsinn Holding Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 86. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Offered
Table 87. Helsinn Holding Main Business
Table 88. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Helsinn Holding Latest Developments
Table 90. Eisai Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 91. Eisai Postoperative Nausea and Vomiting (PONV) Product Offered
Table 92. Eisai Main Business
Table 93. Eisai Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Eisai Latest Developments
Table 95. Merck Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 96. Merck Postoperative Nausea and Vomiting (PONV) Product Offered
Table 97. Merck Main Business
Table 98. Merck Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Merck Latest Developments
Table 100. GlaxoSmithKline Details, Company Type, Postoperative Nausea and Vomiting (PONV) Area Served and Its Competitors
Table 101. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Offered
Table 102. GlaxoSmithKline Main Business
Table 103. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Postoperative Nausea and Vomiting (PONV) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Postoperative Nausea and Vomiting (PONV) Sales Market Share by Country/Region (2023)
Figure 8. Postoperative Nausea and Vomiting (PONV) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type in 2023
Figure 10. Postoperative Nausea and Vomiting (PONV) in Hospital Pharmacies
Figure 11. Global Postoperative Nausea and Vomiting (PONV) Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. Postoperative Nausea and Vomiting (PONV) in Online Pharmacies
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 14. Postoperative Nausea and Vomiting (PONV) in Retail Pharmacies
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application in 2023
Figure 17. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Player in 2023
Figure 18. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Postoperative Nausea and Vomiting (PONV) Value Market Share by Country in 2023
Figure 24. United States Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region in 2023
Figure 29. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type in 2023
Figure 30. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application in 2023
Figure 31. China Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Country in 2023
Figure 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 57. United States Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 61. China Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 65. India Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 68. France Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 69. UK Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 78. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Postoperative Nausea and Vomiting (PONV) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Postoperative Nausea and Vomiting (PONV) Sales Market Share by Country/Region (2023)
Figure 8. Postoperative Nausea and Vomiting (PONV) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type in 2023
Figure 10. Postoperative Nausea and Vomiting (PONV) in Hospital Pharmacies
Figure 11. Global Postoperative Nausea and Vomiting (PONV) Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. Postoperative Nausea and Vomiting (PONV) in Online Pharmacies
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 14. Postoperative Nausea and Vomiting (PONV) in Retail Pharmacies
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application in 2023
Figure 17. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Player in 2023
Figure 18. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Postoperative Nausea and Vomiting (PONV) Value Market Share by Country in 2023
Figure 24. United States Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region in 2023
Figure 29. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type in 2023
Figure 30. APAC Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application in 2023
Figure 31. China Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Country in 2023
Figure 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Postoperative Nausea and Vomiting (PONV) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 57. United States Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 61. China Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 65. India Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 68. France Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 69. UK Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Postoperative Nausea and Vomiting (PONV) Market Size 2025-2030 ($ Millions)
Figure 78. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Postoperative Nausea and Vomiting (PONV) Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global 3D Mobile C-Arm Market Growth 2025-2031
US$ 3,660.00
April 2025
77 pages
Global Therapeutic Nuclear Medicines Market Growth 2025-2031
US$ 3,660.00
January 2025
112 pages
Global Vials Rubber Stoppers Caps Market Growth 2024-2030
US$ 3,660.00
March 2024
131 pages
Global Adult Manual Resuscitator Market Growth 2023-2029
US$ 3,660.00
February 2023
110 pages
Global Dietary Polyphenol Supplements Market Growth 2024-2030
US$ 3,660.00
December 2024
114 pages
